Skip to main content
Advertisement
Advertisement

MNOV

MNOV logo

Medicinova, Inc.

1.79
USD
Sponsored
+0.04
+2.29%
Sep 09, 15:59 UTC -4
Closed
exchange

After-Market

1.78

-0.01
-0.28%

MNOV Earnings Reports

Positive Surprise Ratio

MNOV beat 31 of 41 last estimates.

76%

Next Report

Date of Next Report
Nov 11, 2026
Estimate for Q3 26 (Revenue/ EPS)
$51.00K
/
-$0.06
Implied change from Q2 26 (Revenue/ EPS)
-88.86%
/
+20.00%
Implied change from Q3 25 (Revenue/ EPS)
-58.64%
/
--

Medicinova, Inc. earnings per share and revenue

On Aug 13, 2026, MNOV reported earnings of -0.05 USD per share (EPS) for Q2 26, beating the estimate of -0.06 USD, resulting in a 22.60% surprise. Revenue reached 458.00 thousand, compared to an expected 51.00 thousand, with a 798.04% difference. The market reacted with a 0.00% price change (close before vs. close after earnings).
Looking ahead to Q3 26, -- analysts forecast an EPS of -0.06 USD, with revenue projected to reach 51.00 thousand USD, implying an increase of 20.00% EPS, and decrease of -88.86% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Clinuvel Pharmaceuticals Limited - ADR
Report Date
Aug 27, 2026 For Q4 26
Estimate
$0.50
Actual
-
Surprise
-
FAQ
For Q2 2026, Medicinova, Inc. reported EPS of -$0.05, beating estimates by 22.6%, and revenue of $458.00K, 798.04% above expectations.
The stock price moved -- 0%, changed from $1.31 before the earnings release to $1.31 the day after.
The next earning report is scheduled for Nov 11, 2026.
Based on -- analysts, Medicinova, Inc. is expected to report EPS of -$0.06 and revenue of $51.00K for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement